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Inflammation is generally present in many diseases that involve bone
including fractures, bone infections, arthritis, wear particle-induced
periprosthetic osteolysis, osteonecrosis and others. Furthermore,
increased bone deposition is desirable in spine fusion, joint arthrodesis,
and fracture nonunion, clinical scenarios in which inflammation is often
prominent. Persisting, dysregulated inflammation is deleterious to bone by
increasing bone destruction and diminishing bone formation. However,
little is known about the interactions between inflammatory leukocytes,
and cells of the mesenchymal stem cell/osteoblast lineage. This is
surprising, given that inflammation is recognized to be the first stage of
bone healing. Thus, interactions between cells of the monocyte/macro-
phage lineage and those of the mesenchymal stem cell (MSC)/osteoblast
lineage are crucial to bone health and maintenance. Mesenchymal stem
cells (MSCs) have been found in cord blood and peripheral blood (PB) of
mammalian species including human, guinea pig, mice, rat, dog, horse and
rabbit at low frequency. The number of MSCs in PB (PB-MSCs) is rare and
their biological role was not fully defined. Increased numbers of
circulating MSCs in peripheral blood in patients with long bone fracture,
non-union and in patients with cancers PB-MSCs have been found and the
PB-MSCs may play very important roles in development, repair and disease
progression. PB-MSCs may be used for disease monitoring, diagnosis, cell
and gene therapy applications. Understanding and modulating the cross-
talk between inflammatory cells and osteoprogenitors may provide
opportunities for optimizing bone physiology, and suggest important
strategies for enhancing tissue engineering of bone.i.org/10.1016/j.jot.2016.06.013SpeakersSpeaker 1: Macrophages, osteoprogenitors and bone
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